Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 7:13:1180099.
doi: 10.3389/fonc.2023.1180099. eCollection 2023.

Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis

Affiliations

Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis

Yaqi Wu et al. Front Oncol. .

Erratum in

Abstract

Background: Previous genetic-epidemiological studies considered TERT (rs2736100), CCDC26 (rs4295627), CDKN2A/B (rs4977756) and RTEL1 (rs6010620) gene polymorphisms as the risk factors specific to glioma. However, the data samples of previous genetic-epidemiological studies are modest to determine whether they have definite association with glioma.

Method: The study paid attention to systematically searching databases of PubMed, Embase, Web of Science (WoS), Scopus, Cochrane Library and Google Scholars. Meta-analysis under 5 genetic models, namely recessive model (RM), over-dominant model (O-DM), allele model (AM), co-dominant model (C-DM) and dominant model (DM) was conducted for generating odds ratios (ORs) and 95% confidence intervals (CIs). That was accompanied by subgroup analyses according to various racial groups. The software STATA 17.0 MP was implemented in the study.

Result: 21 articles were collected. According to data analysis results, in four genetic models (AM, RM, DM and C-DM) TERT gene rs2736100 polymorphism, CCDC26 gene rs4295627 polymorphism, CDKN2A/B gene rs4977756 polymorphism and RTEL1 gene rs6010620 polymorphisms increased the risk of glioma in Caucasians to different degrees. In Asian populations, the CCDC26 gene rs4295627 polymorphism and CDKN2A/B gene rs4977756 polymorphism did not exhibit a relevance to the risk of glioma. It is suggested to cautiously explain these results as the sample size is small.

Conclusion: The current meta-analysis suggested that the SNP of TERT (rs2736100), CCDC26 (rs4295627), CDKN2A/B (rs4977756) and RTEL1 (rs6010620) genes in glioma might increase risk of glioma, but there are ethnic differences. Further studies evaluating these polymorphisms and glioma risk are warranted.

Keywords: genetic model; glioma; meta-analysis; risk; single nucleotide polymorphism.

PubMed Disclaimer

Conflict of interest statement

Author LH was employed by ICON Plc. The remaining authors declare the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of the study selection and exclusion criteria from this meta-analysis.
Figure 2
Figure 2
Forest plots of meta-analyses for correlation of glioma and rs2736100 SNP under all models. (A) allele model; (B) recessive model; (C) co-dominant model (Homozygote); (D) co-dominant model (Heterozygote); (E) dominant model; (F) over-dominant model.
Figure 3
Figure 3
Forest plots of meta-analyses for correlation of glioma and rs4295627 SNP under all models. (A) allele model; (B) recessive model; (C) co-dominant model (Homozygote); (D) co-dominant model (Heterozygote); (E) dominant model; (F). over-dominant model.
Figure 4
Figure 4
Forest plots of meta-analyses for correlation of glioma and rs4977756 SNP under all models. (A) allele model; (B) recessive model; (C) co-dominant model (Homozygote); (D) co-dominant model (Heterozygote); (E) dominant model; (F) over-dominant model.
Figure 5
Figure 5
Forest plots of meta-analyses for correlation of glioma and rs6010620 SNP under all models. (A) allele model; (B) recessive model; (C) co-dominant model (Homozygote); (D) co-dominant model (Heterozygote); (E) dominant model; (F). over-dominant model.

Similar articles

Cited by

References

    1. Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, et al. . Annual report to the nation on the status of cancer 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 103:714–36. doi: 10.1093/jnci/djr077 - DOI - PMC - PubMed
    1. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. . The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (2016) 131:803–20. doi: 10.1007/s00401-016-1545-1 - DOI - PubMed
    1. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. . The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol (2021) 23:1231–51. doi: 10.1093/neuonc/noab106 - DOI - PMC - PubMed
    1. Bell EH, Zhang P, Fisher BJ, Macdonald DR, McElroy JP, Lesser GJ, et al. . Association of MGMT promoter methylation status with survival outcomes in patients with high-risk glioma treated with radiotherapy and temozolomide: an analysis from the NRG oncology/RTOG 0424 trial. JAMA Oncol (2018) 4:1405–9. doi: 10.1001/jamaoncol.2018.1977 - DOI - PMC - PubMed
    1. Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, et al. . Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med (2019) 25:477–86. doi: 10.1038/s41591-018-0337-7 - DOI - PMC - PubMed

Publication types